Board Meeting Outcome for Revised Outcome Of Board Meeting
Filed with BSE · · 12 pages · English
The Board, based on the recommendations of the Audit Committee and the Committee of Independent Directors, has considered and approved a Scheme of Merger/Amalgamation among Hatri Pharma Private Limited and Venmax Drugs and Pharmaceuticals Limited (“VDPL” or the “Company” or the “Merger/Amalgamated Company”) and their respective shareholders and creditors (the “Scheme”) under Sections 230 to 232 of
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 02 2025
- Reg. 34 (1) Annual Report.
- Board Meeting Outcome for Outcome Of The Board Meeting
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 25 2025
- Closure of Trading Window
Later from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2025
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 27 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 29 2025
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals